A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo
In vivo decorporation of U(VI) from bones is an unsolved challenge because of the formation of stable uranium phosphate complexes. Here, the authors develop a hydroxypyridonone-based ligand with strong uranium complexation and low cytotoxicity. They find this ligand effectively removes uranium from...
Guardado en:
Autores principales: | Xiaomei Wang, Xing Dai, Cen Shi, Jianmei Wan, Mark A. Silver, Linjuan Zhang, Lanhua Chen, Xuan Yi, Bizheng Chen, Duo Zhang, Kai Yang, Juan Diwu, Jianqiang Wang, Yujie Xu, Ruhong Zhou, Zhifang Chai, Shuao Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f5f19fdfda140a9b8a4128474a4e8c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Overcoming the crystallization and designability issues in the ultrastable zirconium phosphonate framework system
por: Tao Zheng, et al.
Publicado: (2017) -
Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals
por: Xu Zhou, et al.
Publicado: (2021) -
Bioremediation of Uranium- and Nitrate-Contaminated Groundwater after the In Situ Leach Mining of Uranium
por: Rehemanjiang Wufuer, et al.
Publicado: (2021) -
Double dative bond between divalent carbon(0) and uranium
por: Wei Su, et al.
Publicado: (2018) -
Rare earth separations by selective borate crystallization
por: Xuemiao Yin, et al.
Publicado: (2017)